Search

everythinglearnresearchcommunity

for

Search:↓

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

The developed scaffold effectively treats chronic wounds by promoting healing and preventing infection.

Natural products can help heal wounds by affecting key biological pathways.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Some traditional Chinese medicines may have anti-aging benefits and could help with hair growth, but more research is needed.

PRP therapy's success varies and depends on PRP quality and patient condition, with athletes benefiting more.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

taVNS reduces vitiligo symptoms in mice.

Large data can lead to new medical discoveries and personalized medicine.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Higher air pollution increases the risk of alopecia areata.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.